Lipisafe CV 20 Capsule is a combination medication containing Atorvastatin 20 mg and Clopidogrel 75 mg, indicated for the management of cardiovascular risk in patients with atherosclerotic cardiovascular disease or those at high risk of thrombotic events. Atorvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels, thereby reducing the progression of atherosclerosis. Clopidogrel, an antiplatelet agent, inhibits platelet aggregation by irreversibly blocking the P2Y12 ADP receptor on platelet cell membranes, preventing thrombus formation. The combined action of these agents provides a dual approach in reducing the risk of myocardial infarction, stroke, and other vascular complications in patients with established coronary artery disease, peripheral arterial disease, or cerebrovascular disease. Lipisafe CV 20 Capsule is typically prescribed as part of a comprehensive cardiovascular risk management plan, including lifestyle modifications such as diet, exercise, and smoking cessation. It is important to monitor liver function tests and complete blood counts periodically during therapy. Contraindications include active bleeding, severe hepatic impairment, and hypersensitivity to either component. Patients should be advised to report any signs of bleeding or muscle pain promptly.

Dosage & How to Use